Renova is exploring new therapeutic opportunities that have the potential to expand the use of Renova’s gene therapy platform to include several pathologies associated with diabetes and heart failure.
Read MoreRenova Has Prioritized Two Primary Regulatory Pathways Where It Is Poised to Launch Pivotal Human Trials for Its Promising Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Read MoreHealthy Heart's medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center's patients
Read MoreMore than five million Americans are suffering from this disease but many people are still unaware of this condition. Many people are only aware of high blood pressure which is they fail to recognize the important signs of congestive heart disease.
Read More